Nanobiotix Appoints Dr. Alain Herrera to the Supervisory Board  
2/13/2013 6:20:46 AM

Nanobiotix (Euronext: NANO / ISIN: FR0011341205), the oncology focused nanomedicine company, announced today that Dr. Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun in their roles, as part of a planned Supervisory Board succession.